Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of cotrimoxazole, ciprofloxacin, and cefixime for uncomplicated cystitis in adult women
IRCT20200414047073N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- May 2020
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of trimethoprim + sulfamethoxazole, ciprofloxacin and cefixime in cystitis and urinary tract infection (UTI) (3 arms), sponsored by Islamic Azad University. Primary endpoint: Cystitis symptoms. Started May 2020; status: completed.
02
Drugs
trimethoprim + sulfamethoxazoleciprofloxacincefixime
03
Conditions
cystitisurinary tract infection (UTI)
Beyond the preview
Go deeper on IRCT20200414047073N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200414047073N1.